Fennec Pharmaceuticals (FENC) Treasury Shares (2021 - 2025)
Fennec Pharmaceuticals (FENC) posted Treasury Shares of $314000.0 for Q4 2025, down 25.06% on a QoQ basis from $419000.0 in Q3 2025, and down 3.09% year-over-year from $324000.0 in Q4 2024.
Fennec Pharmaceuticals (FENC) Treasury Shares (2021 - 2025) Analysis & Trends
Fennec Pharmaceuticals' Treasury Shares history runs 5 years deep, the most recent figure standing at $314000.0 for Q4 2025.
- Quarterly Treasury Shares fell 3.09% year-over-year to $314000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $314000.0 (down 3.09% YoY) and the FY2025 annual result came in at $387000.0, up 19.44% from the prior year.
- Treasury Shares was $314000.0 for Q4 2025 at Fennec Pharmaceuticals, down from $419000.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $589000.0 in Q1 2025 and bottomed at $35000.0 in Q4 2022.
- A 5-year average of $244473.7 and a median of $219000.0 in 2021 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2022 — Treasury Shares sank 84.02% — and 2023, when it jumped 522.86%.
- Fennec Pharmaceuticals' Treasury Shares stood at $219000.0 in 2021, then sank by 84.02% to $35000.0 in 2022, then soared by 522.86% to $218000.0 in 2023, then soared by 48.62% to $324000.0 in 2024, then slipped by 3.09% to $314000.0 in 2025.
- Business Quant data shows FENC's Treasury Shares at $314000.0 in Q4 2025, $419000.0 in Q3 2025, and $100000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Fennec Pharmaceuticals | 346.75 Mn | 309.97 Mn | 12.01 Mn | 314,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 314,000.00 |
| Dec 31, 2025 | 314,000.00 |
| Sep 30, 2025 | 419,000.00 |
| Sep 30, 2025 | 419,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 589,000.00 |
| Mar 31, 2025 | 589,000.00 |
| Dec 31, 2024 | 324,000.00 |
| Dec 31, 2024 | 324,000.00 |
| Sep 30, 2024 | 367,000.00 |
| Sep 30, 2024 | 367,000.00 |
| Jun 30, 2024 | 445,000.00 |
| Jun 30, 2024 | 445,000.00 |
| Mar 31, 2024 | 214,000.00 |
| Mar 31, 2024 | 214,000.00 |
| Dec 31, 2023 | 218,000.00 |
| Dec 31, 2023 | 218,000.00 |
| Sep 30, 2023 | 260,000.00 |
| Sep 30, 2023 | 260,000.00 |